Peer-Reviewed Publication
Nat Med2025;31(9):3121-3127.September 1, 2025Journal Article

Multimodal AI correlates of glucose spikes in people with normal glucose regulation, pre-diabetes and type 2 diabetes.

Mattia Carletti1, Jay Pandit1, Matteo Gadaleta1, Danielle Chiang1, Felipe Delgado1, Katie Quartuccio1, Brianna Fernandez1, Juan Antonio Raygoza Garay1, Ali Torkamani1, Riccardo Miotto2, Hagai Rossman3, Benjamin Berk4, Katie Baca-Motes1,4, Vik Kheterpal4, Eran Segal5, Eric J Topol1, Edward Ramos6,7, Giorgio Quer8
1Scripps Research Translational Institute, La Jolla, CA, USA.
2Tempus AI, Chicago, IL, USA.
3Pheno.AI, Tel-Aviv, Israel.
4CareEvolution, Ann Arbor, MI, USA.
5Weizmann Institute, Rehovot, Israel.
6Scripps Research Translational Institute, La Jolla, CA, USA. eramos@scripps.edu.
7CareEvolution, Ann Arbor, MI, USA. eramos@scripps.edu.
8Scripps Research Translational Institute, La Jolla, CA, USA. gquer@scripps.edu.

Abstract

Type 2 diabetes (T2D) is a multifaceted disease associated with several factors, including diet, genetics, exercise, sleep and gut microbiome. Current diagnostic and monitoring methods based on episodic assays like glycated hemoglobin (HbA1c) fail to capture its full complexity. Here, in a prospective cohort of 1,137 participants in the United States, we analyzed multimodal data from 347 deeply ph…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.